The AGE Reader assists physicians in focusing treatment on patients with the highest risk of complications. This includes patients suffering from diabetes mellitus, renal failure but also acute disorders like acute coronary syndromes and sepsis.
The non-invasive AGE Reader measurement adds value particularly to the classic risk factors that predict the cardiovascular risk of diabetes patients. The AGE Reader measurement reflects the glycometabolic memory which is not covered by the classic risk markers. Therefore it adds clinically relevant information to the cardiovascular risk prediction for diabetes patients.
In diabetes patients the AGE Reader:
The information of the AGE Reader measurement is especially interesting for the following applications:
Would you like to learn more about our products? Request any information you wish to receive here.
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.